For part 3 of our interview with Katie Abouzahr, MD, Johnson & Johnson Innovative Medicine, we discuss the favorable safety ...
Recent insights shed light onto the most effective diagnostic tools for laryngeal myasthenia gravis (MG), a poorly understood and often misdiagnosed condition, is most reliably. A new study shows ...
UCB, a global biopharmaceutical company, today announced the CHMP (Committee for Medicinal Products for Human Use) has issued a positive opinion for the self-administration of RYSTIGGO® ...
Abby Smith, 40, a NHS manager from Reading, has the rare autoimmune disease myasthenia gravis, which means she needs her ...
As symptoms worsen, they often spread throughout ... thereby providing therapeutic effects for patients with severe myasthenia gravis mediated by autoantibodies. It received approval from the ...
New research at the University of Alberta may make it easier to diagnose serious diseases that disrupt the body's energy ...
Understanding the ins and outs of a rare disease like atypical hemolytic uremic syndrome (aHUS) is a difficult task for ...
Approval in Myasthenia gravis in key markets could eventually ... and continued to suffer from significant unresolved disease symptoms. These can include difficulties seeing, walking, talking ...
The UK regulatory authority has cleared the path for some patients with generalised myasthenia gravis (gMG ... struggle to manage the debilitating symptoms of this rare autoimmune disease." ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback